Fatal pheochromocytoma crisis precipitated by dobutamine stress echocardiography

European Journal of Echocardiography

Volumn 9, Issue 6, 2008, Pages 819-821

  Sethi, Prabhdeep S ^a   Hiser, William ^a   Gaffar, Hasan ^a   Jiang, Leng ^a   Islam, Ashequl ^a   Bhatnagar, Nitin ^a   Slawsky, Mara ^a  

^a BAYSTATE MEDICAL CENTER   (United States)

Author keywords

Dobutamine echocardiography; Pheochromocytoma crisis; Stress echocardiography; Stress testing; Ventricular tachycardia

Indexed keywords

DOBUTAMINE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; ELECTROCARDIOGRAPHY; FEMALE; HEART VENTRICLE TACHYCARDIA; HUMAN; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; STRESS ECHOCARDIOGRAPHY;

ADRENAL GLAND NEOPLASMS; DOBUTAMINE; ECHOCARDIOGRAPHY, STRESS; FATAL OUTCOME; FEMALE; HUMANS; MIDDLE AGED; PHEOCHROMOCYTOMA; RESPIRATORY INSUFFICIENCY; SHOCK; SYMPATHOMIMETICS;

EID: 54949100817     PISSN: 15252167     EISSN: 15322114     Source Type: Journal    
DOI: 10.1093/ejechocard/jen180     Document Type: Article

References (12)

1. Lenders JWM, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet 2005;366:665-75.
2. Baguet J, Hammer L, Mazzuco TL, Chabre O, Mallion J, Sturm N et al. Circumstances of discovery of phaechromotycoma: a retrospective study of 41 consecutive patients. Eur J Endocrinol 2004;150:681-6.
3. Mathias W, Arruda A, Santos FC, Arruda AL, Mattos E, Osorio A et al. Safety of dobutamine-atropine stress echocardiography: a prospective experience of 4,033 consecutive studies. J Am Soc Echocardiogr 1999;12:785-91.
4. Poldermans D, Rambaldi R, Bax JJ, Cornel JH, Thomson IR, Valkema R et al. Safety and utility of atropine addition during dobutamine stress echocardiography for the assessment of viable myocardium in patients with severe left ventricular dysfunction. Eur Heart J 1998;19:1712-18.
5. Picano E, Mathias W, Pingitore A, Bigi R, Previtali M. Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multicentre study. Echo dobutamine international cooperative study group. Lancet. 1994;344:1190-2.
6. Varga A, Garcia MA, Picano E. Safety of stress echocardiography (from the International Stress Echo Complication Registry). Am J Cardiol 2006;98:541-3.
7. Katritsis DG, Karabinos I, Papadopoulos A, Simeonidis P, Korovesis S, Giazitzoglou E et al. Sustained ventricular tachycardia induced by dobutamin stress echocardiography: a prospective study. Europace 2005;7:433-9.
8. Shaw TR, Rafferty P, Tait GW. Transient shock and myocardial impairment caused by phaeochromotycoma crisis. Br Heart J 1987;57:194-8.
9. Parkes SI, Cameron DP. Phaechromocytoma and cardiomyopathy. Med J Aust 1988;148:94-6.
10. Bouloux P-MG, Fakeeh M. Investigation of phaeochromocytoma. Clin Endocrinol 1995;43:657-64.
11. Raisanen J, Shapiro B, Glazer GM, Desai S, Sisson JC. Plasma catecholamines in pheochromocytoma: effect of urographic contrast media. Am J Roentgenol 1984;143:43-6.
12. Brown H, Goldberg PA, Selter JG, Cabin HSS, Marieb NJ, Udelsman R et al. Hemorrhagic pheochromocytoma associated with systemic corticosteroid therapy and presenting as myocardial infarction with severe hypertension. J Clin Endocrinol Metab 2005;90:563-9.